Public Employees Retirement System of Ohio Acquires 2,566 Shares of Astera Labs, Inc. $ALAB

Public Employees Retirement System of Ohio boosted its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 4.0% in the first quarter, Holdings Channel reports. The institutional investor owned 67,056 shares of the company’s stock after acquiring an additional 2,566 shares during the period. Public Employees Retirement System of Ohio’s holdings in Astera Labs were worth $7,349,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Reflection Asset Management purchased a new position in shares of Astera Labs in the 4th quarter valued at $25,000. Smartleaf Asset Management LLC lifted its stake in shares of Astera Labs by 422.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after purchasing an additional 152 shares during the last quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA purchased a new stake in shares of Astera Labs during the 4th quarter worth $33,000. Wexford Capital LP bought a new stake in Astera Labs during the third quarter valued at about $39,000. Finally, National Bank of Canada FI boosted its position in Astera Labs by 159.0% during the third quarter. National Bank of Canada FI now owns 202 shares of the company’s stock valued at $39,000 after purchasing an additional 124 shares in the last quarter. Institutional investors own 60.47% of the company’s stock.

Analysts Set New Price Targets

ALAB has been the topic of several analyst reports. Roth Capital reiterated a “buy” rating and issued a $275.00 target price on shares of Astera Labs in a research note on Wednesday, May 6th. Stifel Nicolaus increased their price target on shares of Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a research report on Wednesday, June 24th. Northland Securities cut shares of Astera Labs from an “outperform” rating to a “market perform” rating in a report on Tuesday, May 26th. JPMorgan Chase & Co. lifted their price objective on shares of Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 6th. Finally, Evercore reiterated an “outperform” rating and set a $297.00 price objective on shares of Astera Labs in a research note on Tuesday, May 19th. Twelve research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $282.00.

Astera Labs Price Performance

Shares of ALAB stock opened at $260.23 on Wednesday. Astera Labs, Inc. has a 1-year low of $97.89 and a 1-year high of $499.48. The stock’s fifty day moving average price is $360.60 and its 200 day moving average price is $227.59. The company has a market cap of $44.61 billion, a price-to-earnings ratio of 175.83, a price-to-earnings-growth ratio of 3.27 and a beta of 3.66.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. During the same period in the prior year, the company posted $0.33 EPS. The firm’s quarterly revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, equities research analysts anticipate that Astera Labs, Inc. will post 1.86 earnings per share for the current year.

Insider Buying and Selling at Astera Labs

In related news, COO Sanjay Gajendra sold 400,000 shares of Astera Labs stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $290.30, for a total value of $116,120,000.00. Following the completion of the sale, the chief operating officer directly owned 5,064,213 shares in the company, valued at $1,470,141,033.90. This trade represents a 7.32% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the business’s stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $450.00, for a total transaction of $1,577,250.00. Following the sale, the director directly owned 57,466 shares in the company, valued at approximately $25,859,700. This represents a 5.75% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 1,676,845 shares of company stock valued at $444,928,806. Insiders own 10.40% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.